{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T22:19:14Z","timestamp":1790547554115,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003056","name":"Ente Cassa di Risparmio di Firenze","doi-asserted-by":"publisher","award":["MANNECRF14"],"award-info":[{"award-number":["MANNECRF14"]}],"id":[{"id":"10.13039\/501100003056","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.neuropharm.2018.01.014","type":"journal-article","created":{"date-parts":[[2018,1,12]],"date-time":"2018-01-12T12:57:16Z","timestamp":1515761836000},"page":"403-413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"special_numbering":"C","title":["Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy"],"prefix":"10.1016","volume":"131","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9605-5852","authenticated-orcid":false,"given":"F.","family":"Resta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Micheli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Laurino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Spinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Sartiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Di Cesare Mannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Cerbai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Ghelardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.N.","family":"Romanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Mannaioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Masi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2018.01.014_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4161\/chan.19126","article-title":"KCNE2 and the K (+) channel: the tail wagging the dog","volume":"6","author":"Abbott","year":"2012","journal-title":"Channels (Austin)"},{"key":"10.1016\/j.neuropharm.2018.01.014_bib2","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.8053.1","article-title":"Chemotherapy-induced peripheral neuropathy: an update on the current understanding","volume":"5","author":"Addington","year":"2016","journal-title":"F1000Res"},{"key":"10.1016\/j.neuropharm.2018.01.014_bib3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1634\/theoncologist.2014-0044","article-title":"Platinum-induced neurotoxicity and preventive strategies: past, present, and future","volume":"20","author":"Avan","year":"2015","journal-title":"Oncologist"},{"key":"10.1016\/j.neuropharm.2018.01.014_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2515\/therapie\/2009013","article-title":"Heart rate reduction: beneficial effects in heart failure and post-infarcted myocardium","volume":"64","author":"Berdeaux","year":"2009","journal-title":"Therapie"},{"key":"10.1016\/j.neuropharm.2018.01.014_bib5","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1152\/physrev.00029.2008","article-title":"Hyperpolarization-activated cation channels: from genes to function","volume":"89","author":"Biel","year":"2009","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.pmn.2008.04.002","article-title":"Chronic neuropathic pain in women after breast cancer treatment","volume":"10","author":"Bokhari","year":"2009","journal-title":"Pain Manag. Nurs."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib7","doi-asserted-by":"crossref","first-page":"H355","DOI":"10.1152\/ajpheart.00154.2009","article-title":"Effects of KCNE2 on HCN isoforms: distinct modulation of membrane expression and single channel properties","volume":"297","author":"Brandt","year":"2009","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib8","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/jns5.12073","article-title":"Chemotherapy-induced peripheral neurotoxicity (CIPN): what we need and what we know","volume":"19","author":"Cavaletti","year":"2014","journal-title":"J.\u00a0Peripher. Nerv. Syst."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib9","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1016\/S0959-8049(01)00300-8","article-title":"Effects of different schedules of OXA treatment on the peripheral nervous system of the rat","volume":"37","author":"Cavaletti","year":"2001","journal-title":"Eur. J. Canc."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib10","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1089\/dna.2013.2021","article-title":"Novel role of KT5720 on regulating hyperpolarization-activated cyclic nucleotide-gated channel activity and dorsal root ganglion neuron excitability","volume":"32","author":"Cheng","year":"2013","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1097\/00115550-200505000-00006","article-title":"Peripheral block of the hyperpolarization-activated cation current (Ih) reduces mechanical allodynia in animal models of postoperative and neuropathic pain","volume":"30","author":"Dalle","year":"2005","journal-title":"Reg. Anesth. Pain Med."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib12","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/j.1476-5381.2011.01782.x","article-title":"Novel blockers of hyperpolarization-activated current with isoform selectivity in recombinant cells and native tissue","volume":"166","author":"Del Lungo","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib13","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1002\/emmm.201100134","article-title":"OXA-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors","volume":"3","author":"Descoeur","year":"2011","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib14","doi-asserted-by":"crossref","first-page":"42021","DOI":"10.1038\/srep42021","article-title":"Astragali radix: could it be an adjuvant for OXA-induced neuropathy?","volume":"7","author":"Di Cesare Mannelli","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1113\/jphysiol.1986.sp016177","article-title":"Properties of the hyperpolarizing-activated current (if) in cells isolated from the rabbit sino-atrial node","volume":"377","author":"DiFrancesco","year":"1986","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib16","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2174\/138161209788186281","article-title":"Hyperpolarization-activated cyclic nucleotide-gated (HCN) channels and pain","volume":"15","author":"Dunlop","year":"2009","journal-title":"Curr. Pharmaceut. Des."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib17","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1126\/science.1206243","article-title":"HCN2 ion channels play a central role in inflammatory and neuropathic pain","volume":"333","author":"Emery","year":"2011","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2018.01.014_bib18","first-page":"219","article-title":"Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man","volume":"50","author":"Freireich","year":"1966","journal-title":"Cancer Chemother. Rep."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1113\/jphysiol.1985.sp015573","article-title":"Conduction velocity is related to morphological cell type in rat dorsal root ganglion neurones","volume":"359","author":"Harper","year":"1985","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib20","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.pain.2007.10.011","article-title":"Axonal accumulation of hyperpolarization-activated cyclic nucleotide-gated cation channels contributes to mechanical allodynia after peripheral nerve injury in rat","volume":"137","author":"Jiang","year":"2008","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2018.01.014_bib21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ygyno.2015.01.524","article-title":"Basic science and clinical management of painful and non-painful chemotherapy-related neuropathy","volume":"136","author":"Kim","year":"2015","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib22","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1111\/bph.13032","article-title":"3-iodothyroacetic acid, a metabolite of thyroid hormone, induces itch and reduces threshold to noxious and to painful heat stimuli in mice","volume":"172","author":"Laurino","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib23","first-page":"417","article-title":"Hyperpolarization-activated, cation-nonselective, cyclic nucleotide-modulated channel blockade alleviates mechanical allodynia and suppresses ectopic discharge in spinal nerve ligated rats","volume":"6","author":"Lee","year":"2005","journal-title":"J.\u00a0Pain"},{"issue":"9","key":"10.1016\/j.neuropharm.2018.01.014_bib24","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1111\/ejn.13066","article-title":"Differential contribution of Ih to the integration of excitatory synaptic inputs in substantia nigra pars compacta and ventral tegmental area dopaminergic neurons","volume":"42","author":"Masi","year":"2015","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib25","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.1111\/bph.12955","article-title":"Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP","volume":"172","author":"McGrath","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib26","doi-asserted-by":"crossref","first-page":"6773","DOI":"10.1021\/jm1006758","article-title":"Design, synthesis, and preliminary biological evaluation of new isoform-selective f-current blockers","volume":"53","author":"Melchiorre","year":"2010","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib27","doi-asserted-by":"crossref","first-page":"5911","DOI":"10.1113\/jphysiol.2008.163154","article-title":"Role of the hyperpolarization-activated current Ih in somatosensory neurons","volume":"586","author":"Momin","year":"2008","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib28","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.2174\/1568026616999160315130832","article-title":"HCN channels modulators: the need for selectivity","volume":"16","author":"Novella Romanelli","year":"2016","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib29","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1146\/annurev.ph.58.030196.001503","article-title":"Queer current and pacemaker: the hyperpolarization-activated cation current in neurons","volume":"58","author":"Pape","year":"1996","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib30","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nrd3576","article-title":"Exploring HCN channels as novel drug targets","volume":"10","author":"Postea","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib31","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1096\/fj.07-9574LSF","article-title":"Dose translation from animal to human studies revisited","volume":"22","author":"Reagan-Shaw","year":"2008","journal-title":"Faseb. J."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib32","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.neuropharm.2016.04.038","article-title":"Kynurenic acid and zaprinast induce analgesia by modulating HCN channels through GPR35 activation","volume":"108","author":"Resta","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2018.01.014_bib33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1006\/gyno.1997.4832","article-title":"A\u00a0randomized, multicenter, double-blind, placebo-controlled, dose-finding study of ORG 2766 in the prevention or delay of cisplatin-induced neuropathies in women with ovarian cancer","volume":"67","author":"Roberts","year":"1997","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pain.2009.09.003","article-title":"OXA-induced neuropathy in the rat: involvement of oxalate in cold hyperalgesia but not mechanical allodynia","volume":"147","author":"Sakurai","year":"2009","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2018.01.014_bib35","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1124\/pr.117.014035","article-title":"The hyperpolarization-activated cyclic nucleotide-gatedc: from biophysics to pharmacology of a unique family of ion channels","volume":"69","author":"Sartiani","year":"2017","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib36","first-page":"676","article-title":"Fiji: an open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib37","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neuroscience.2015.03.041","article-title":"Increased expression of HCN2 channel protein in L4 dorsal root ganglion neurons following axotomy of L5- and inflammation of L4-spinal nerves in rats","volume":"295","author":"Smith","year":"2015","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.01.014_bib38","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1111\/jce.12212","article-title":"Chronic atrial fibrillation alters the functional properties of if in the human atrium","volume":"24","author":"Stillitano","year":"2013","journal-title":"J.\u00a0Cardiovasc. Electrophysiol."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib39","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.pain.2010.06.020","article-title":"Spinal hyperpolarization-activated cyclic nucleotide-gated cation channels at primary afferent terminals contribute to chronic pain","volume":"151","author":"Takasu","year":"2010","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2018.01.014_bib40","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.neuroscience.2004.06.038","article-title":"Differential roles of neuronal and endothelial nitric oxide synthases during carrageenan-induced inflammatory hyperalgesia","volume":"128","author":"Tao","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2018.01.014_bib41","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1113\/jphysiol.2004.067462","article-title":"Functional bradykinin B1 receptors are expressed in nociceptive neurones and are upregulated by the neurotrophin GDNF","volume":"560","author":"Vellani","year":"2004","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib42","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1523\/JNEUROSCI.23-06-02069.2003","article-title":"Upregulation of the hyperpolarization-activated cation current after chronic compression of the dorsal root ganglion","volume":"23","author":"Yao","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib43","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.pain.2014.05.021","article-title":"Inflammatory and neuropathic pain are rapidly suppressed by peripheral block of hyperpolarisation-activated cyclic nucleotide-gated ion channels","volume":"155","author":"Young","year":"2014","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2018.01.014_bib44","doi-asserted-by":"crossref","first-page":"E84","DOI":"10.1161\/hh1201.093511","article-title":"MinK-related peptide 1: a beta subunit for the HCN ion channel subunit family enhances expression and speeds activation","volume":"88","author":"Yu","year":"2001","journal-title":"Circ. Res."},{"key":"10.1016\/j.neuropharm.2018.01.014_bib45","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/ALN.0000000000000176","article-title":"Enhanced excitability of primary sensory neurons and altered gene expression of neuronal ion channels in dorsal root ganglion in paclitaxel-induced peripheral neuropathy","volume":"120","author":"Zhang","year":"2014","journal-title":"Anesthesiology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818300145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390818300145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T05:26:02Z","timestamp":1570598762000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390818300145"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":45,"alternative-id":["S0028390818300145"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.01.014","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selective HCN1 block as a strategy to control oxaliplatin-induced neuropathy","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2018.01.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}